Source Bioscience Company News



Company:
Epic Code:
ISIN No:
StockName:
Group:
Sector:
Sub Sector:
Country:
Region:
Market:
Market Cap:

SOURCE BIOSCIENCE PLC
SBS
GB0009739649
ORD GBP0.02
4573
Pharmaceuticals & Biotechnology
Biotechnology
UK
Midlands
UK Main Market
17.7829571976 GBPm


Data as of 10:00 23/09/2009. Check director details and other company announcments at Source Bioscience Website .



RNS News for Source Bioscience





Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.



Latest Source Bioscience News



Global Healthcare Analytical Testing Services Market 2017: Source Bioscience ...
Digital Journal - Aug 7, 2017
Deerfield Beach, FL -- (SBWIRE) -- 08/07/2017 -- The Global Healthcare Analytical Testing Services Market 2017 Industry Research Report is a in-depth study and professional analysis on the current state of the Healthcare Analytical Testing Services market.

08/07/2017 07:22 PM


Why I'd consider buying Essentra plc and Equiniti Group plc today
AOL UK - Jul 28, 2017
The good news came in the form of 100% client retention across all divisions, with new wins including Aon Hewitt, British Bankers' Association and House of Fraser, and fresh mandates from Alpha FX, Arix Bioscience, Global Ports, Ramsdens and Xafinity.

07/28/2017 10:43 AM


Arix Bioscience participates in $20 million fundraise for Mitoconix Bio
GlobeNewswire (press release) - Jun 27, 2017
LONDON, 27 June, 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or the "Company"), a global healthcare and life science company supporting medical innovation, today announces that it has acquired an interest in Mitoconix Bio Ltd.
Mitoconix Bio Raises $20 Million in Series A Funding to Develop ... - PharmiWeb.com (press release)

06/27/2017 12:03 PM


Arix Bioscience leads $65 million Series B investment round for Iterum
GlobeNewswire (press release) - May 19, 2017
LONDON, 19 May, 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, today announced that Iterum, a new Arix Group Business, has closed a Series B ...
Iterum Secures $65 Million in Series B Financing - PR Newswire (press release)
Medtech firm working on new antibiotic closes huge eight-figure Series B - Bdaily

05/19/2017 07:11 AM


Biotech giant backed by Neil Woodford confirms £100m London float
City A.M. - Feb 2, 2017
UK healthcare giant Arix Bioscience, backed by biotech entrepreneur Sir Chris Evans and star investor Neil Woodford, is hoping to raise £100m in a stock market float in London.

02/02/2017 12:50 PM


Investors make Source BioScience takeover offer
Insider Media - Jul 29, 2016
The board of Nottingham laboratory services and products provider Source BioScience has accepted a takeover bid which values the business at almost £63m.

07/29/2016 10:56 AM